Medical AI Alliance
← Company Index
Medical DevicesKONEX 0668304 approvals

GENOTECH CORP.

Official website

Supplies synthetic genes (GenOligo) and DNA sequencing analysis services for biotech research.

As of 2026-10-09, GENOTECH CORP. has 4 Korean MFDS device approvals, 15 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 1997 and listed on KONEX in 2016, Genotech is a medical device company specializing in gene synthesis and analysis. It supplies synthetic genes (GenOligo, Kit) used as essential materials in biotech research, along with gene analysis services that sequence customer-submitted samples. Revenue is split 58.5% from synthetic gene products, 41.3% from gene analysis services, and 0.2% from other sources such as leasing and merchandise sales.

Products & technology

  • Synthetic genes (GenOligo, Kit)Essential material for gene manipulation, PCR, cloning, and sequencing in biotech research
  • Gene analysis serviceSequencing of customer-submitted samples and delivery of analysis results

Regulatory approvals

data.go.kr

4 Korean MFDS device approvals · 2005–2014

  • MFDSOther reagents, classⅡ, for molecular diagnostics2014-05-30
    Product approval · Class 2체외 제인 14-1103 호
  • MFDSIVD reagents for histocompatibility antigen, antibody not for transfusion or transplantation but for specific disease diagnosis, molecular diagnostics2014-05-30
    Product approval · Class 2체외 제인 14-1104 호
  • MFDSIVD reagents for infectious disease marker(Diagnosis of Sexually transmitted disease, Legally designated infectious pathogens other than ‘high risk pathogens’, Infectious agents with moderate infectivity), molecular diagnosticsRevoked2013-01-02
    Product approval · Class 3체외 제허 13-76 호
  • MFDSOrthopedic materialsRevoked2005-09-20
    Product approval · Class 2수허 05-880 호

Publications

PubMed · affiliation-matched
Show 5 more publications

Patents

KIPRIS · applicant-matched
Show 60 more patents

AI reads

MAA server logs · IP-verified
27
Times AI engines pulled GENOTECH CORP.'s records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

24
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

1
live 0
Last 7 days
19
live 3
Last 30 days
27
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot13
  • GoogleGoogleOther4
  • PerplexityPerplexityBot3
  • MicrosoftBingbot2
  • AnthropicClaudeBot2

Measured since Aug 27, 2026 · 5 AI engines · last read Oct 4, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for GENOTECH CORP. and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies approved for the same productsMedical Devices

Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.

OSANG HEALTHCARE CO.,LTD.3 shared

Founded 1996, listed on KOSDAQ in 2024, OSANG HEALTHCARE develops and sells biochemistry, immunodiagnostic, and molecular IVD products.

LabGenomics. Co., Ltd.3 shared

KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.

CG Invites Co., Ltd.2 shared

Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.

BIONEERCORPORATION2 shared

Bioneer, founded in 1992 and KOSDAQ-listed in 2005, provides gene analysis equipment, molecular diagnostics, and RNAi drug development.

SEEGENE, INC.2 shared

Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.

NanoenTek,Inc.1 shared

Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.

HUMASIS CO., LTD.1 shared

KOSDAQ-listed IVD company producing COVID-19 and HIV point-of-care diagnostic reagents alongside rubber products and entertainment businesses.

NGeneBio Co., Ltd.1 shared

KOSDAQ-listed precision-diagnostics company manufacturing genomic diagnostic reagents and developing related software.

PCL. Inc1 shared

KOSDAQ-listed IVD company using SG Cap™ multiplex diagnostic technology for infectious disease, cancer, and companion animal testing.

Sugentech, Inc.1 shared

Founded in 2011 and KOSDAQ-listed in 2019, Sugentech develops multiplex immunoblot, point-of-care, and digital healthcare diagnostics.

Optipharm.CO.,LTD1 shared

Optipharm, founded in 2000 and KOSDAQ-listed in 2018, provides animal disease diagnostics, animal medicine, and biotech.

Genomictree Inc.1 shared

Cancer molecular diagnostics company behind the EarlyTect-C stool-based colorectal cancer test using the SDC2 methylation biomarker.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition